# PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma

> **NCT07047807** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 50 (estimated)

## Conditions studied

- PDAC - Pancreatic Ductal Adenocarcinoma

## Interventions

- **BEHAVIORAL:** PDAC-PATHWAYS
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT07047807
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-06
- **Primary completion:** 2027-05
- **Final completion:** 2027-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07047807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07047807, "PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07047807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*